Literature DB >> 9458369

Characterization of CCK-B/gastrin-like receptors in human gastric carcinoma.

J P Smith1, A H Shih, M G Wotring, P J McLaughlin, I S Zagon.   

Abstract

In this study we identified and characterized the receptor related to the modulation of growth of human gastric cancer by gastrin. By performing receptor binding assays on human AGS gastric cancer cells with the selective CCK-B/gastrin receptor antagonist [3H]L-365,260, specific and saturable binding were determined. Binding was dependent on protein concentration, time, temperature, and the presence of protease inhibitors, and was located in the membrane fraction. Gastrin, as well as CCK, stimulated gastric cancer cell growth in a receptor-mediated fashion at a concentration consistent with the binding affinity. Receptor gene expression for the CCK-B/gastrin receptor, but not for the CCK-A receptor, was found by reverse transcription polymerase chain reaction. Receptor binding assays as well as transcriptional and growth studies provide evidence that gastrin-stimulated growth of human gastric cancer is mediated by CCK-B/gastrin-like receptors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9458369

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  16 in total

1.  Bioconjugation of calcium phosphosilicate composite nanoparticles for selective targeting of human breast and pancreatic cancers in vivo.

Authors:  Brian M Barth; Rahul Sharma; Erhan I Altinoğlu; Thomas T Morgan; Sriram S Shanmugavelandy; James M Kaiser; Christopher McGovern; Gail L Matters; Jill P Smith; Mark Kester; James H Adair
Journal:  ACS Nano       Date:  2010-03-23       Impact factor: 15.881

2.  Downregulation of the CCK-B receptor in pancreatic cancer cells blocks proliferation and promotes apoptosis.

Authors:  Kristin K Fino; Gail L Matters; Christopher O McGovern; Evan L Gilius; Jill P Smith
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-22       Impact factor: 4.052

Review 3.  Signaling from novel splice variants of hormone receptors in cancer.

Authors:  Wei-Qun Ding; Laurence J Miller
Journal:  Int J Gastrointest Cancer       Date:  2002

4.  Incidence and treatment of metachronous gastric cancer after proximal gastrectomy.

Authors:  Yoshinori Iwata; Seiji Ito; Kazunari Misawa; Yuichi Ito; Koji Komori; Tetsuya Abe; Yasuhiro Shimizu; Masahiro Tajika; Yasumasa Niwa; Kazuhiro Yoshida; Taira Kinoshita
Journal:  Surg Today       Date:  2018-02-19       Impact factor: 2.549

5.  Long-term effects of proglumide on resection of cardiac adenocarcinoma.

Authors:  Yu-Ping Chen; Jie-Sheng Yang; Di-Tian Liu; Wei-Ping Yang
Journal:  World J Gastroenterol       Date:  2005-05-07       Impact factor: 5.742

6.  Distribution of cholecystokinin-B receptor genotype between patients with pancreatic cancer and controls and its impact on survival.

Authors:  Jill P Smith; David C Whitcomb; Gail L Matters; Randall E Brand; Jiangang Liao; Yu-Jing Huang; Marsha L Frazier
Journal:  Pancreas       Date:  2015-03       Impact factor: 3.327

7.  Vaccine against gastrin, a polyclonal antibody stimulator, decreases pancreatic cancer metastases.

Authors:  Nicholas Osborne; Rebecca Sundseth; Martha D Gay; Hong Cao; Robin D Tucker; Sandeep Nadella; Shangzi Wang; Xunxian Liu; Alexander Kroemer; Lynda Sutton; Allen Cato; Jill P Smith
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-08-21       Impact factor: 4.052

8.  Signaling through cholesterol esterification: a new pathway for the cholecystokinin 2 receptor involved in cell growth and invasion.

Authors:  Michael R Paillasse; Philippe de Medina; Guillaume Amouroux; Loubna Mhamdi; Marc Poirot; Sandrine Silvente-Poirot
Journal:  J Lipid Res       Date:  2009-06-05       Impact factor: 5.922

9.  Growth of human pancreatic cancer is inhibited by down-regulation of gastrin gene expression.

Authors:  Gail L Matters; John F Harms; Christopher O McGovern; Calpurnia Jayakumar; Keisha Crepin; Zachary P Smith; Melissa C Nelson; Heather Stock; Craig W Fenn; James Kaiser; Mark Kester; Jill P Smith
Journal:  Pancreas       Date:  2009-07       Impact factor: 3.327

10.  Germline Mutation of the CCK Receptor: A Novel Biomarker for Pancreas Cancer.

Authors:  Jelal Alsubai; Gail L Matters; Christopher O McGovern; Jiangang Liao; Evan L Gilius; Jill P Smith
Journal:  Clin Transl Gastroenterol       Date:  2016-01-07       Impact factor: 4.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.